Stock Exchange Announcement no. 6/2007
2 April 2007
Coloplast has completed the divestment of its Breast
Care business unit
Coloplast's divestment of its Breast Care business unit to Granville Baird
Capital Partners Advisors Limited is completed.
The Breast Care business unit includes the legal entity Amoena
Medizin-Orthopädie-Technik GmbH and certain breast care activities performed by
Coloplast A/S and its subsidiaries.
The transaction will result in non-recurring income of around DKK 440m, which
will be included in the interim financial statement due 15 May, 2007. The
results of Breast Care will be included in the interim financial statement as
net profit from discontinued operations. Comparative figures will be restated
before the interim financial statement.
All terms and estimates remain as stated in Coloplast's stock exchange
announcement of 12 February 2007.
Sten Scheibye
President, CEO
Further information
Investors and financial analysts
Jørgen Fischer Ravn
Head of Investor relations
Tel. +45 3085 1308
E-mail: dkjfr@coloplast.com
Press and the media
Jens Tovborg Jensen
Head of Media relations
Tel. +45 3085 1922
E-mail: dkjto@coloplast.com
This announcement is available in a Danish and an English language version.
In the event of discrepancies, the Danish version shall prevail.
